Portfolio (Quarterly)
Guide ↗
Davern Capital Partners, LP
· CIK 0002003147| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | PFE | PFIZER INC | Healthcare | 2,042,242.0 | $50.9M | 16.44% | NEW | — | $24.90 | +3.3% |
| 2 | REGN | REGENERON PHARMACEUTICALS | Healthcare | 52,420.0 | $40.5M | 13.08% | NEW | — | $771.87 | -17.5% |
| 3 | BNTX | BIONTECH SE | Healthcare | 371,216.0 | $35.3M | 11.43% | NEW | — | $95.20 | -2.4% |
| 4 | RPRX | ROYALTY PHARMA PLC | Healthcare | 840,650.0 | $32.5M | 10.50% | NEW | — | $38.64 | +39.7% |
| 5 | ARGX | ARGENX SE | Healthcare | 35,685.0 | $30.0M | 9.70% | NEW | — | $840.95 | -4.1% |
| 6 | LEGN | LEGEND BIOTECH CORP | Healthcare | 1,056,668.0 | $23.0M | 7.43% | NEW | — | $21.74 | +35.4% |
| 7 | ROIV | ROIVANT SCIENCES LTD | Healthcare | 1,028,298.0 | $22.3M | 7.21% | NEW | — | $21.70 | +36.4% |
| 8 | IONS | IONIS PHARMACEUTICALS INC | Healthcare | 238,477.0 | $18.9M | 6.10% | NEW | — | $79.11 | -4.0% |
| 9 | NTRA | NATERA INC | Healthcare | 78,650.0 | $18.0M | 5.83% | NEW | — | $229.09 | -11.8% |
| 10 | LLY | ELI LILLY & CO | Healthcare | 8,307.0 | $8.9M | 2.89% | NEW | — | $1074.68 | +0.2% |
| 11 | VRDN | VIRIDIAN THERAPEUTICS INC | Healthcare | 261,615.0 | $8.1M | 2.63% | NEW | — | $31.12 | -45.2% |
| 12 | MLYS | MINERALYS THERAPEUTICS INC | Healthcare | 210,648.0 | $7.6M | 2.47% | NEW | — | $36.29 | -15.8% |
| 13 | CGON | CG ONCOLOGY INC | Healthcare | 162,005.0 | $6.7M | 2.17% | NEW | — | $41.52 | +49.5% |
| 14 | ABVX | ABIVAX SA | Healthcare | 48,502.0 | $6.5M | 2.12% | NEW | — | $134.85 | -6.8% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%